| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 209.167 | 84 |
| GSM780708 | Untreated after 4 days (C2_1) | 168.298 | 82 |
| GSM780709 | Untreated after 4 days (C3_1) | 188.404 | 83 |
| GSM780719 | Untreated after 4 days (C1_2) | 202.088 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 194.233 | 83 |
| GSM780721 | Untreated after 4 days (C3_2) | 186.801 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 205.48 | 84 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 206.306 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 161.095 | 81 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 164.717 | 81 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 160.672 | 81 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 172.878 | 82 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 199.138 | 84 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 204.336 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 163.044 | 81 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 165.598 | 82 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 184.033 | 83 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 184.429 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 161.428 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 187.987 | 83 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 198.691 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 187.391 | 83 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 170.774 | 82 |